J B Chemicals News

Certificate under Reg.74 (5) of SEBI (DP) Regulations, 2018

Intimation of Trading Window closure period

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Receipt of Order

NovaaOne Capital Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Corrigendum to the Public Announcement, Detailed Public Statement and the Draft Letter of Offer for the attention of the eligible shareholders of JB Chemicals & Pharmaceuticals Ltd ("Target Company").

Allotment of equity shares on exercise of stock options pursuant to employee stock option scheme

Cessation of Non-Executive Independent Director upon completion of term

Allotment of Equity Shares on exercise of Stock Options pursuant to Employee Stock Option Scheme

Allotment of Equity shares on exercise of Stock Options pursuant to Employee Stock Option Scheme

Result of Voting at Annual General Meeting alongwith Scrutinizer''s Report on Voting

Change in Registered office of the Company

Appointment of Secretarial Auditors

Re-appointment of Statutory Auditors

Re-appointment of Mr. Nikhil Chopra as CEO and Whole-time Director

Re-appointment of Mr. Sumit Bose as Non-Executive Independent Director of the Company

Appointment of Ms. Richa Arora as Non-Executive Independent Director of the Company

Appointment of Mr. Ashwani Kumar Puri as Non-Executive Independent Director of the Company

Proceedings of the Annual General Meeting

Transcript of Investor / Analyst call

Audio recording of Investors/analysts call with Management

Newspaper advertisement pertaining to financial results for quarter ended June 30, 2025

Investor Presentation

Press Release

Unaudited standalone and consolidated financial results for the quarter ended on June 30, 2025 accompanied by limited review report.

Investors/analysts call with Management

Allotment of equity shares on exercise of stock options pursuant to Employee Stock Option Scheme

JB Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2025 ,inter alia, to consider and approve the unaudited financial results for the quarter ended on June 30, 2025

The Nifty Pharma index closed 0.27 per cent down at 22531.85.

Letter to shareholders - Integrated Annual Report 2024-25

Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018

Newspaper advertisement

NovaaOne Capital Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Draft Letter of Offer to the Public Shareholders of JB Chemicals & Pharmaceuticals Ltd ("Target Company").

BRSR

Intimation of Record date

Annual Report For the Financial Year 2024-25

Notice of Annual General Meeting to be held on August 6, 2025 at 1:30 pm.

Change in Director - Appointment of Non-Executive Independent Director

Newspaper Publication of Detailed Public Statement in connection with the open offer

The NSE Nifty index closed 55.71 points up at 25461.0

NovaaOne Capital Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Detailed Public Statement in terms of Regulations 3(1) and 4 read with Regulations 13(4), 14 (3) and 15(2) and other applicable Regulations of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended, to the eligible Shareholders of JB Chemicals & Pharmaceuticals Ltd ("Target Company").

Stock market today: As the Nifty forms a bearish engulfing pattern, technical analysts suggest the market may enter a consolidation phase. While global cues remain supportive, domestic factors and earnings season are expected to shape short-term trends. Mid- and small-cap stocks showed resilience on expectations of stronger earnings and margin expansion.